Canada markets closed

  • S&P/TSX
    18,380.96
    +255.24(+1.41%)

  • S&P 500
    3,841.94
    +73.47(+1.95%)

  • DOW
    31,496.30
    +572.16(+1.85%)

RepliCel Life Sciences Inc. (RP.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.3600-0.0400 (-10.00%)
At close: 2:48PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
Total Revenue
252.609
252.609
121.114
0
Operating Expenses
Research Development
982.162
2,196
709.26
2,542
Selling General and Administrative
1,021
1,074
2,151
3,450
Total Operating Expenses
2,003
3,270
2,860
5,992
Operating Income or Loss
-1,751
-3,018
-2,739
-5,992
Interest Expense
-
141.427
-
-
Total Other Income/Expenses Net
-126.924
64.109
-29.817
-29.19
Income Before Tax
-1,903
-2,954
-2,769
-6,014
Income from Continuing Operations
-1,903
-2,954
-2,769
-6,014
Net Income
-1,903
-2,954
-2,769
-6,014
Net Income available to common shareholders
-1,903
-2,954
-2,769
-6,014
Basic EPS
-
-0.12
-0.12
-0.32
Diluted EPS
-
-0.12
-0.12
-0.32
Basic Average Shares
-
24,107
22,661
18,680
Diluted Average Shares
-
24,107
22,661
18,680
EBITDA
-
-3,016
-2,736
-5,988